FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971695978> ?p ?o ?g. }

• W1971695978 endingPage "94" @default.
• W1971695978 startingPage "85" @default.
• W1971695978 abstract "The high-affinity receptor for IgG, Fc gamma RI, expressed on monocytes and interferon-gamma (IFN-gamma)-stimulated neutrophils, is a trigger molecule for cell-mediated cytotoxicity. We have prepared murine monoclonal antibodies (MoAb 22 and MoAb 32) that bind to Fc gamma RI outside the ligand binding site and thus bind to and trigger cytotoxicity that is not competed by other immunoglobulins. Because of these properties, it seemed that these MoAbs would be very useful for the development of bispecific antibodies (BsAb) for targeting normal cellular immune defense mechanisms as a new form of immunotherapy for treatment of cancer. BsAbs incorporate into a single molecule the binding specifities of two different antibodies, and, thus, can be used to target myeloid cells to tumors, ensure activation of cellular cytotoxic mechanisms, and target cell lysis and/or phagocytosis. BsAbs were prepared using anti-Fc gamma RI MoAb and an anti-myeloid cell MoAb, PM81, reactive with the CD15 antigen, for studies of antibody-dependent cellular cytotoxicity. Conjugates were made by cross-linking sulfhydryl groups of Fab fragments of MoAb 32 or 22 (both IgG1) and sulfhydryl groups added to intact PM81 (an IgM) using N-succinimdyl-acetyl-S-thioacetate (SATA). The resulting product was purified by high-performance size-exclusion chromatography. The ability of the BsAbs to mediate attachment of human monocytes to tumor target cells was confirmed in a microtiter well assay of binding of MTT-labeled U937 cells (a human Fc gamma RI-bearing cell line) to SKBR-3 (PM81-reactive breast carcinoma) target cells. The ability of the BsAbs to mediate killing of HL-60 promyelocytic leukemia cells was studied using a 6-hour Chromium-51 release assay. Effector cells were monocytes obtained by cytopheresis and cultured for 18 hours with IFN-gamma. Monocytes alone caused minimal killing (5-20%), monocytes plus BsAb caused moderate killing (20-50%), and monocytes plus BsAb plus human serum resulted in maximal killing (50-80%). Experiments were performed to test the ability of the BsAb to purge bone marrow of small numbers of leukemia cells using bone marrow mononuclear phagocytes treated for 18 hours with IFN-gamma prior to adding target cells. Without the addition of human serum as a source of complement, a 90% depletion of clonogenic HL-60 cells could be demonstrated. With human complement, up to 95% depletion was seen. Thus, this BsAb possessed the ability to lyse tumor cell targets by two different mechanisms, complement and cell-mediated lysis.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W1971695978 created "2016-06-24" @default.
• W1971695978 creator A5048589296 @default.
• W1971695978 creator A5051393786 @default.
• W1971695978 creator A5054831844 @default.
• W1971695978 creator A5061663602 @default.
• W1971695978 creator A5065883808 @default.
• W1971695978 creator A5086364075 @default.
• W1971695978 date "1992-01-01" @default.
• W1971695978 modified "2023-09-23" @default.
• W1971695978 title "Initial Trial of Bispecific Antibody-Mediated Immunotherapy of CD15-Bearing Tumors: Cytotoxicity of Human Tumor Cells Using a Bispecific Antibody Comprised of Anti-CD15 (MoAb PM81) and Anti-CD64/FcγRI (MoAb 32)" @default.
• W1971695978 cites W1515819565 @default.
• W1971695978 cites W1963772597 @default.
• W1971695978 cites W1985837387 @default.
• W1971695978 cites W2015657041 @default.
• W1971695978 cites W2023236831 @default.
• W1971695978 cites W2090125712 @default.
• W1971695978 cites W2183656856 @default.
• W1971695978 cites W2410336081 @default.
• W1971695978 cites W342440787 @default.
• W1971695978 doi "https://doi.org/10.1089/scd.1.1992.1.85" @default.
• W1971695978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1365020" @default.
• W1971695978 hasPublicationYear "1992" @default.
• W1971695978 type Work @default.
• W1971695978 sameAs 1971695978 @default.
• W1971695978 citedByCount "29" @default.
• W1971695978 countsByYear W19716959782013 @default.
• W1971695978 countsByYear W19716959782017 @default.
• W1971695978 countsByYear W19716959782018 @default.
• W1971695978 crossrefType "journal-article" @default.
• W1971695978 hasAuthorship W1971695978A5048589296 @default.
• W1971695978 hasAuthorship W1971695978A5051393786 @default.
• W1971695978 hasAuthorship W1971695978A5054831844 @default.
• W1971695978 hasAuthorship W1971695978A5061663602 @default.
• W1971695978 hasAuthorship W1971695978A5065883808 @default.
• W1971695978 hasAuthorship W1971695978A5086364075 @default.
• W1971695978 hasConcept C10205521 @default.
• W1971695978 hasConcept C109316439 @default.
• W1971695978 hasConcept C115085202 @default.
• W1971695978 hasConcept C147483822 @default.
• W1971695978 hasConcept C153911025 @default.
• W1971695978 hasConcept C159654299 @default.
• W1971695978 hasConcept C185592680 @default.
• W1971695978 hasConcept C202751555 @default.
• W1971695978 hasConcept C203014093 @default.
• W1971695978 hasConcept C2776447464 @default.
• W1971695978 hasConcept C2776804306 @default.
• W1971695978 hasConcept C2779931124 @default.
• W1971695978 hasConcept C28328180 @default.
• W1971695978 hasConcept C40677261 @default.
• W1971695978 hasConcept C542903549 @default.
• W1971695978 hasConcept C55493867 @default.
• W1971695978 hasConcept C86803240 @default.
• W1971695978 hasConcept C95444343 @default.
• W1971695978 hasConceptScore W1971695978C10205521 @default.
• W1971695978 hasConceptScore W1971695978C109316439 @default.
• W1971695978 hasConceptScore W1971695978C115085202 @default.
• W1971695978 hasConceptScore W1971695978C147483822 @default.
• W1971695978 hasConceptScore W1971695978C153911025 @default.
• W1971695978 hasConceptScore W1971695978C159654299 @default.
• W1971695978 hasConceptScore W1971695978C185592680 @default.
• W1971695978 hasConceptScore W1971695978C202751555 @default.
• W1971695978 hasConceptScore W1971695978C203014093 @default.
• W1971695978 hasConceptScore W1971695978C2776447464 @default.
• W1971695978 hasConceptScore W1971695978C2776804306 @default.
• W1971695978 hasConceptScore W1971695978C2779931124 @default.
• W1971695978 hasConceptScore W1971695978C28328180 @default.
• W1971695978 hasConceptScore W1971695978C40677261 @default.
• W1971695978 hasConceptScore W1971695978C542903549 @default.
• W1971695978 hasConceptScore W1971695978C55493867 @default.
• W1971695978 hasConceptScore W1971695978C86803240 @default.
• W1971695978 hasConceptScore W1971695978C95444343 @default.
• W1971695978 hasIssue "1" @default.
• W1971695978 hasLocation W19716959781 @default.
• W1971695978 hasLocation W19716959782 @default.
• W1971695978 hasOpenAccess W1971695978 @default.
• W1971695978 hasPrimaryLocation W19716959781 @default.
• W1971695978 hasRelatedWork W1967470546 @default.
• W1971695978 hasRelatedWork W1997275703 @default.
• W1971695978 hasRelatedWork W2033032152 @default.
• W1971695978 hasRelatedWork W2049463037 @default.
• W1971695978 hasRelatedWork W2061223989 @default.
• W1971695978 hasRelatedWork W2067077431 @default.
• W1971695978 hasRelatedWork W2094936714 @default.
• W1971695978 hasRelatedWork W2369078388 @default.
• W1971695978 hasRelatedWork W2417631503 @default.
• W1971695978 hasRelatedWork W2443772760 @default.
• W1971695978 hasVolume "1" @default.
• W1971695978 isParatext "false" @default.
• W1971695978 isRetracted "false" @default.
• W1971695978 magId "1971695978" @default.
• W1971695978 workType "article" @default.